IS

Irukulapati Shanti Simha

Active Director Director DIN 11012985
DIN 11012985 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Irukulapati Shanti Simha

Data last updated:

Irukulapati Shanti Simha is a Director at Episolus Pharma Private Limited (since 2025).

DIN 11012985
Primary Designation Director
First Appointment 21 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Episolus Pharma Private Limited U47721TS2025PTC195888
Director21 Mar 20252025Active

Board colleagues of Irukulapati Shanti Simha

Directorship timeline

Open interactive timeline →
Episolus Pharma Private Limited
Premium access

Shareholding and investment profile for Irukulapati Shanti Simha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Irukulapati Shanti Simha

Irukulapati Shanti Simha currently holds 1 directorship: Episolus Pharma Private Limited (Director, since 21 Mar 2025).

Irukulapati Shanti Simha was first appointed on 21 Mar 2025 as Director at Episolus Pharma Private Limited.

The current boards of Irukulapati Shanti Simha's companies include Aravind Galla (Episolus Pharma Private Limited), Harita Boddu (Episolus Pharma Private Limited), Irukulapati Varun Sai (Episolus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available